Management of Unresectable Stage III NSCLC

In this downloadable slideset, Mark M. Awad, MD, PhD, juxtaposes historical data for concurrent CRT with new evidence for immune checkpoint therapy in the care of patients with stage III NSCLC.
Format: Microsoft PowerPoint (.ppt)
File Size: 1.09 MB
Released: April 27, 2018

Acknowledgements

This activity is supported by an educational grant from
AstraZeneca

Related Content

Download this PDF resource of expert recommendations on the optimal use of immune checkpoint inhibitors in patients with advanced NSCLC, including therapy selection and adverse event management.

Released: April 30, 2018

In this downloadable slideset, Sandra Cuellar, PharmD, BCOP, reviews pharmacy perspectives in the assessment and management of adverse events associated with immune checkpoint therapy in the care of patients with stage III NSCLC.

Released: April 27, 2018

In this downloadable slideset, Ali McBride PharmD, MS, BCOP, FAzPA, explores the underlying rationale for immune checkpoint inhibitor therapy in the care of patients with stage III NSCLC.

Released: April 27, 2018

Expert faculty from the 2017-2018 CCO Local Live meeting series “Expert Strategies to Optimize the Treatment of Patients With Squamous NSCLC” answer frequently asked questions about treating squamous NSCLC, including considerations regarding tumor mutational burden, optimal sequencing of therapy, and future directions.

Edward S. Kim, MD
Program Director
Mark A. Socinski, MD
Program Director
person default Paul K. Paik, MD Nathan Pennell, MD, PhD Thomas Stinchcombe, MD
Released: April 26, 2018

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?